Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253


A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.

Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, Tong DK, Law S, Chan KW, Ma S, Guan XY.

Cancer Res. 2013 Apr 1;73(7):2322-32. doi: 10.1158/0008-5472.CAN-12-2991. Epub 2013 Feb 4.


Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.

Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.

Ann Surg Oncol. 2010 May;17(5):1311-23. doi: 10.1245/s10434-009-0895-5. Epub 2010 Jan 12.


Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.

Ann Surg Oncol. 2009 Sep;16(9):2494-501. doi: 10.1245/s10434-009-0559-5. Epub 2009 Jun 13.


Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.

Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY.

Cancer Res. 2010 Nov 1;70(21):8832-41. doi: 10.1158/0008-5472.CAN-10-0779. Epub 2010 Oct 26.


STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.

Kita Y, Mimori K, Iwatsuki M, Yokobori T, Ieta K, Tanaka F, Ishii H, Okumura H, Natsugoe S, Mori M.

Ann Surg Oncol. 2011 Jan;18(1):261-72. doi: 10.1245/s10434-010-1271-1. Epub 2010 Aug 24.


miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.

Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.

Oncotarget. 2015 May 10;6(13):10964-77.


Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.


FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.

Nishida N, Mimori K, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M.

Ann Surg Oncol. 2011 Feb;18(2):535-42. doi: 10.1245/s10434-010-1274-y. Epub 2010 Aug 28.


Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma.

Yu MA, Kiang A, Wang-Rodriguez J, Rahimy E, Haas M, Yu V, Ellies LG, Chen J, Fan JB, Brumund KT, Weisman RA, Ongkeko WM.

PLoS One. 2012;7(12):e51967. doi: 10.1371/journal.pone.0051967. Epub 2012 Dec 26.


Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.

Zhu YH, Fu L, Chen L, Qin YR, Liu H, Xie F, Zeng T, Dong SS, Li J, Li Y, Dai Y, Xie D, Guan XY.

Cancer Res. 2013 Apr 1;73(7):2298-309. doi: 10.1158/0008-5472.CAN-12-2663. Epub 2013 Feb 22.


MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.

Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li M, Cao RS, Hao B, Zhang HJ, Qiu HQ, Shi RH.

Br J Cancer. 2014 Nov 11;111(10):2003-13. doi: 10.1038/bjc.2014.485. Epub 2014 Sep 11.


Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?

Shi M, Wang Z, Song L, Wang D, Sun Z.

Med Oncol. 2014 May;31(5):951. doi: 10.1007/s12032-014-0951-2. Epub 2014 Apr 16.


BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.

Xu G, Tang S, Yang J, Chen K, Kang J, Zhao G, Feng F, Yang X, Zhao L, Lu Q, Sun L, Hong L, Gong T, Zhang H.

Dig Dis Sci. 2013 Jul;58(7):1871-9. doi: 10.1007/s10620-013-2611-3. Epub 2013 Mar 17. Erratum in: Dig Dis Sci. 2013 Aug;58(8):2429-30.


Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.

Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY.

Gastroenterology. 2014 Jun;146(7):1701-13.e9. doi: 10.1053/j.gastro.2014.02.029. Epub 2014 Feb 21.


Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma.

Sudo T, Iwaya T, Nishida N, Sawada G, Takahashi Y, Ishibashi M, Shibata K, Fujita H, Shirouzu K, Mori M, Mimori K.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S324-35. doi: 10.1245/s10434-012-2418-z. Epub 2012 May 30.


XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Shiozaki A, Kosuga T, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Iitaka D, Nakashima S, Shimizu H, Ishimoto T, Kitagawa M, Nakou Y, Kishimoto M, Liu M, Otsuji E.

Ann Surg Oncol. 2013 Sep;20(9):3140-50. doi: 10.1245/s10434-012-2474-4. Epub 2012 Jul 18.


Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Zhu S, Li Y, Mi L, Zhang Y, Zhang L, Gong L, Han X, Yao L, Lan M, Chen Z, Zhang W.

Dig Dis Sci. 2011 Dec;56(12):3569-76. doi: 10.1007/s10620-011-1812-x. Epub 2011 Jul 26.


Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.


Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.

Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y, Liu Z.

Clin Cancer Res. 2006 Mar 1;12(5):1639-46.


Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.

Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.


Supplemental Content

Support Center